Tesi etd-01102022-225332
Link copiato negli appunti
Tipo di tesi
Master di Secondo Livello
Autore
ALITER, HASHEM
Indirizzo email
alitermd@gmail.com
URN
etd-01102022-225332
Titolo
Severe Mitral regurgitation :Pathophysiology and treatment .
Struttura
Istituto di Scienze della Vita
Corso di studi
Corsi Alta Formazione - PERCUTANEOUS INTERVENTIONAL TREATMENT OF STRUCTURAL HEART DISEASES
Commissione
relatore Prof. BERTI, SERGIO
Membro MEUCCI, FRANCESCO
Membro MEUCCI, FRANCESCO
Parole chiave
- coronary artery disease
- mitral regurgitation
- mitral valve surgery
- transcatheter mitral interventions.
Data inizio appello
21/01/2022;
Disponibilità
completa
Riassunto analitico
Ischemic mitral regurgitation (IMR) is one of the most challenging complications of acute myocardial infarction (AMI) and chronic coronary artery disease (CAD). The presence of IMR, irrespective of severity significantly have a negative impact on the short and long-term outcomes of patients with AMI and CAD. Nearly 25% of patients with AMI without congestive heart failure (CHF) develop IMR and this number approaches 50% when CHF is present. IMR occurs in approximately 20—25% of patients followed up after myocardial infarction (MI) [1—3] and in 50% of those with post-infarct congestive heart failure (CHF) [4]. In patients with CHF, even a mild degree of mitral regurgitation (MR) adversely affects survival. Increasing MR severity is associated with a progressively worse 5-year survival rate [1, 4].
This review is a concise overview of IMR and we will attempt to focus on the fundamentals of SMR and potential treatments for this challenging disease state.
This review is a concise overview of IMR and we will attempt to focus on the fundamentals of SMR and potential treatments for this challenging disease state.
File
| Nome file | Dimensione |
|---|---|
| Doc5_converted.pdf | 274.00 Kb |
Contatta l'autore |
|